Evidence map›Paper›PMID 42734515›Full record

ArticleJournal of chemical information and modeling2026

Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes.

Miguel Sánchez-Marín, Marco Giulini, Alexandre M J J Bonvin

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Assessing structural prediction accuracy for nanobody-small molecule complexes.Protein engineering, design & selection : PEDS · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miguel Sánchez-MarínBijvoet Centre for Biomolecular Research, Faculty of Science─Chemistry, Utrecht University, Padualaan 8, 3584Utrecht, CH, The Netherlands.ORCID 0009-0004-8473-266X
Marco GiuliniBijvoet Centre for Biomolecular Research, Faculty of Science─Chemistry, Utrecht University, Padualaan 8, 3584Utrecht, CH, The Netherlands.
Alexandre M J J BonvinBijvoet Centre for Biomolecular Research, Faculty of Science─Chemistry, Utrecht University, Padualaan 8, 3584Utrecht, CH, The Netherlands.ORCID 0000-0001-7369-1322

Funding

H2020 Research Infrastructures 823830HORIZON EUROPE Digital, Industry and Space 101093290Netherlands e-Science Center 027.020.G13
6 · The paper itself

Abstract

Nanobodies exhibit antigen-binding affinities of the same order as those of antibodies, which, along with their small size and unique structural characteristics, makes them well-suited for therapeutic and diagnostic applications. The lack of coevolutionary signals in nanobody-antigen complexes, together with the broad complementarity determining region 3 loop (CDR3) conformational space, poses a challenge for predicting the 3D structure of those complexes with computational modeling and artificial intelligence-based methods. In this context, physics-based information-driven docking can provide an alternative solution. This study evaluates the state-of-the-art machine-learning-based methods for nanobody structure prediction and benchmarks various HADDOCK workflows to model their interaction with antigens using different input nanobody ensembles and information scenarios. We propose an ensemble docking pipeline that achieves high success rates starting from nanobody structural models predicted by AlphaFold2 and ImmuneBuilder. Provided that some information on the epitope is available, our pipeline achieves higher success rates than the AlphaFold baseline on all generated models.

Indexed as

Antigen-Antibody ComplexAntigensArtificial IntelligenceMolecular Docking SimulationSingle-Domain AntibodiesMachine LearningModels, MolecularPrediction AlgorithmsProtein ConformationAntigen-Antibody ComplexAntigensSingle-Domain Antibodies

Identifiers

PMID42734515
PMCPMC13580113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.